Biomarkers in psychosis: an approach to early identification and individualized treatment

摘要: Numerous biomarkers for somatic disorders are used in routine medical practice. Yet, despite remarkable advances mental health research, we not able to identify with established clinical utility such as schizophrenia. While identification and characterization of crucial first steps this process, their predictive diagnostic treatment need be better developed The heterogeneity psychotic etiologically, pathologically symptomatically presents both a challenge an opportunity the use Simply said, single biomarker might exist that necessitates search profile. In review discuss research findings light approach. We summarize some examples emerging early psychosis delineate how these can applied setting inform on individual basis fostering personalized